AUDUBON, Pa., Nov. 17 (HSMN NewsFeed) — Globus Medical, Inc., the largest privately held spinal implant manufacturer in the world, today announced that its XPand® expandable corpectomy cage was utilized in a totally MIS (minimally invasive surgery) …
Devices, Neurosurgery, Orthopaedic
Globus Medical, corpectomy, XPand system, spine surgery
Posts from ‘November, 2008’
World’s First Totality MIS Corpectomy Procedure with Globus XPand(R) Cage
Stereotaxis Announces European Commercial Release of Magnetic Irrigated Catheter
ST. LOUIS, Nov. 14 (HSMN NewsFeed) — Stereotaxis, Inc. (Nasdaq: STXS ) announced that the commercial launch of its partnered magnetic irrigated catheter will begin next week at centers in Europe. This decision to release the magnetic irrigated catheter …
Devices, Cardiology
Stereotaxis, magnetic irrigated catheter, Niobe
CardioDynamics Announces Two Significant Studies Correlating BioZ(R) With Ejection Fraction (EF)
Stanford Study Finds BioZ® ICG Superior to Echocardiography for Pacemaker Optimization
SAN DIEGO, Nov. 14 (HSMN NewsFeed) — CardioDynamics (Nasdaq: CDIC ), the innovator and leader of Impedance Cardiography (ICG) technology and manufacturer of Bi…
Devices, Cardiology
CardioDynamics, Impedance Cardiography, BioZ, echocardiography
Solos Endoscopy, Inc.’s Mammo View(TM) System Introduced in Puerto Rico to Promote Breast Health
BOSTON, Nov. 14 (HSMN NewsFeed) — Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company has provided equipment to the Advanced Breast Center (ABC) in Puerto Rico for its Mammo View(TM) system. ABC requested the Mammo View(TM…
Devices
Solos Endoscopy, Mammo View, breast cancer
VALEANT PHARMACEUTICALS ACQUIRES DERMATECH
Purchase Expands Valeant’s Dermatology Business in Australia
ALISO VIEJO, Calif., November 14, 2008 - (HSMN NewsFeed) - Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has acquired DermaTech Pty Ltd, an Australian specialty phar…
Biopharmaceuticals, Dermatology, Mergers & Acquisitions
Valeant Pharmaceuticals, DermaTech Pty Ltd
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
LA JOLLA, Calif., Nov. 12 (HSMN NewsFeed) — TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that the Board of Directors has appointed Evelyn Graham as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directo…
Biopharmaceuticals, Personnel
TorreyPines Therapeutics
Amedica Receives CE Mark for the World’s First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System
SALT LAKE CITY, Nov. 12 (HSMN NewsFeed) — Amedica Corporation, an orthopedic implants company focused on silicon nitride ceramic technologies, announced today that it has received a CE (Conformite Europeene) mark for its Valeo(TM) family of ceramic spin…
Devices, Neurosurgery, Orthopaedic, Regulatory
Amedica, Valeo , intervertebral spacers, spine surgery
K2M Obtains Worldwide Exclusive Rights to Revolutionary Injectable Polymer Technology for Treatment of Spinal Disorders
Today’s Announcement Builds on K2M’s Recent Entry into the Biomaterials Market
LEESBURG, Va.–(HSMN NewsFeed)–K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced that it ha…
Devices, Neurosurgery, Orthopaedic
K2M, Promethean Surgical Devices, spine surgery
Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
CLEVELAND, Nov. 12 (HSMN NewsFeed) — Intelect Medical, Inc., an early stage company developing an implantable neuromodulation system for stroke and traumatic brain injury recovery, announced it has closed a licensing and financing deal, led by existing …
Devices, Neurology, Venture Capital
Intelect Medical, Boston Scientific, Greatbatch, neuromodulation
Accera, Inc. Completes $35 Million Series C Financing
BROOMFIELD, Colo., Nov. 11 (HSMN NewsFeed) — Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced it has recently closed a Series C financing round of $35 million (euro 27 million), led by…
Biopharmaceuticals, Venture Capital
Accera, Axona, Ketasyn

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.